2019
DOI: 10.1080/14737167.2019.1650643
|View full text |Cite
|
Sign up to set email alerts
|

Increased burden of disease and role of health economics: Asia-pacific region

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
12
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 19 publications
(12 citation statements)
references
References 128 publications
0
12
0
Order By: Relevance
“…In 2012, COPD patients incurred approximately 14% higher costs than non-COPD patients [8]. The direct cost of management of COPD varies from 35 to 75% of the total cost among different countries [9,10]. COPD also results in significant economic burden to both the patient and society, resulting from productivity losses due to compromised quality of life, early retirement, and disability pension [11].…”
Section: Introductionmentioning
confidence: 99%
“…In 2012, COPD patients incurred approximately 14% higher costs than non-COPD patients [8]. The direct cost of management of COPD varies from 35 to 75% of the total cost among different countries [9,10]. COPD also results in significant economic burden to both the patient and society, resulting from productivity losses due to compromised quality of life, early retirement, and disability pension [11].…”
Section: Introductionmentioning
confidence: 99%
“…The preferred screening methods for HCC in Africa similar to the rest of the world is ultrasound and AFP level [86] . Improvement in Ultrasound technology and the potential use of portable ultrasound machines do offer an opportunity to implement surveillance programs in the continent [87] . Regardless, providing these machines across the continent as well as training of personnel requires a comprehensive effort and multilateral cooperation.…”
Section: Methodology and Frequency Of Surveillancementioning
confidence: 99%
“…According to World Health Organization, COPD is the third leading cause of death [ 2 ]. Moreover, this chronic condition results in a high economic burden: globally, previous studies report that the direct cost of management of COPD ranges from 61% to 89% of the total cost of health care [ 3 , 4 ].…”
Section: Introductionmentioning
confidence: 99%